Kadian

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved July 1996

Specific Treatments:

chronic pain

Find Related Trials for The Following Conditions

General Information

Kadian, a single daily dosage sustained-release morphine product, has been approved by the FDA. Kadian provides relief for chronic moderate to severe pain (pain related to cancer), and has been demonstrated to be as effective when taken once a day as conventional morphine products taken every four hours.